Treatment, Medication & Supplement Directory

A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.

Directory explains “what it is.”Guides explain how owners can discuss, use, monitor, or prepare for a treatment option with veterinary guidance.

29 entriesShowing 25–29

Veterinarian demonstrating safe handling of an unbranded oral oncology medicine with a dog caregiver

Named profile Mitotane in Canine Adrenal Disease and Adrenocortical TumoursRepresentative category illustration – no product packaging is shown.

Chemotherapy · Prescription Drug · Single-agent Chemotherapy · Adrenocorticolytic agents · Dogs · During Chemotherapy · New Diagnosis

Mitotane in Canine Adrenal Disease and Adrenocortical Tumours

mitotane (o,p′-DDD) is covered as adrenocorticolytic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Named profile Hydroxyurea in Veterinary Oncology: Myeloproliferative-Disease ProfileRepresentative category illustration – no product packaging is shown.

Chemotherapy · Prescription Drug · Single-agent Chemotherapy · Ribonucleotide-reductase inhibitors · Dogs & Cats · During Chemotherapy · New Diagnosis

Hydroxyurea in Veterinary Oncology: Myeloproliferative-Disease Profile

hydroxyurea is covered as ribonucleotide-reductase inhibitors; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Named profile Procarbazine in Veterinary Oncology: MOPP/LOPP Component and Safety ProfileRepresentative category illustration – no product packaging is shown.

Chemotherapy · Prescription Drug · Single-agent Chemotherapy · Methylhydrazine antineoplastic agents · Dogs & Cats · During Chemotherapy · New Diagnosis

Procarbazine in Veterinary Oncology: MOPP/LOPP Component and Safety Profile

procarbazine is covered as methylhydrazine antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Calm dog receiving a monitored intravenous treatment in a veterinary clinic

Named profile Paclitaxel in Veterinary Oncology: Formulation and Regulatory-History ProfileRepresentative category illustration – no product packaging is shown.

Chemotherapy · Prescription Drug · Single-agent Chemotherapy · Taxane antineoplastic agents · Dogs · During Chemotherapy · New Diagnosis

Paclitaxel in Veterinary Oncology: Formulation and Regulatory-History Profile

paclitaxel is covered as taxane antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Named profile Docetaxel in Veterinary Oncology: Limited-Evidence Taxane ProfileRepresentative category illustration – no product packaging is shown.